Stroke

Articles

• Stroke Program Survey Includes Data Review, Close Observation

  An inside look at how one agency conducts its stroke survey process.

  Read more

• Health System Tweaks Survey Process, Dramatically Improves Care for Stroke Patients

  Hospitals in the Piedmont Healthcare system in Georgia have made great strides in safety and quality by improving their care for stroke patients. Consolidating some accreditation survey activities was part of the successful strategy.

  Read more

• Investigators Identify Connection Between Vascular Malformation, Gut Bacteria Profile

  The presence of gram-negative bacteria was linked to an abundance of abnormalities known to cause strokes, seizures, and headaches.

  Read more

• Cannabis Use and Stroke Risk: The Debate Continues

  A recently published paper suggests there may be no connection, but the conversation on this topic, as well as the general efficacy of medical marijuana, goes on.

  Read more

• Investigators Uncover More Troubling Data About the Adverse Health Effects of Sugar-Sweetened Beverages

  Recent study revealed women who consume just one such beverage per day were at a much higher risk for stroke and cardiovascular disease.

  Read more

• Dual Antiplatelet Therapy Results in Increase in Serious Hemorrhages Following TIA or Minor Stroke

  The POINT trial showed a 25% reduction in the composite outcome of ischemic stroke, myocardial infarction, or ischemic vascular death in patients treated with clopidogrel plus aspirin for 90 days, immediately following a transient ischemic attack (TIA) or minor acute ischemic stroke. The investigators performed a secondary analysis and found the risk of major hemorrhages was low in both groups, although treatment with clopidogrel and aspirin together increased the risk of major hemorrhages over aspirin alone. Caution should be taken and very close observation of patients maintained when treating with dual antiplatelet therapies.

  Read more

• Smartwatches for the Diagnosis of Atrial Fibrillation

  The Apple Heart Study participants were people without atrial fibrillation who purchased a smart phone app and consented to monitoring using a smartwatch-based irregular pulse notification algorithm, which identified possible atrial fibrillation. If notification occurred, the person was mailed an electrocardiography (ECG) patch to be worn for seven days to confirm the findings first identified by the smartwatch. The age distribution of this group is different than the usual cohort at risk for atrial fibrillation: 52% were between the ages of 22 and 39 years of age, and only 5.9% were 65 years or older. A much more useful study would have included an older cohort that carries a higher risk of atrial fibrillation.

  Read more

• What Is the Optimal Blood Pressure for Secondary Prevention of Stroke?

  High blood pressure is the most prevalent and important risk factor for stroke, and great efforts have been made to reduce blood pressure for both primary and secondary stroke prevention. However, at this time, we do not have evidence to support a firm recommendation for optimal blood pressure management for secondary stroke prevention.

  Read more

• Patients With Stable Coronary Disease and Atrial Fibrillation Are Best Treated With Rivaroxaban, Alone

  Optimal antithrombotic therapy for stroke prevention in patients with atrial fibrillation continues to evolve.Monotherapy with rivaroxiban was noninferior to combination therapy for the primary efficacy endpoint.

  Read more

• Intravenous Thrombolysis Prior to Mechanical Thrombectomy Improves Outcome

  Bridging therapy with intravenous thrombolysis appears to be associated with improved functional outcome without any additional complications compared to direct mechanical thrombectomy for patients with acute ischemic stroke who have LVOs.

  Read more

• First
• Previous
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• Next
• Last